• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型非酒精性脂肪性肝炎(NASH)动物模型:低氧血症增强 NASH 的发展。

A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH.

机构信息

Department of Clinical Pharmaceutical Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan.

出版信息

J Clin Biochem Nutr. 2009 Nov;45(3):335-40. doi: 10.3164/jcbn.09-29. Epub 2009 Oct 28.

DOI:10.3164/jcbn.09-29
PMID:19902025
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2771256/
Abstract

Recent reports described a high incidence of nonalcoholic steatohepatitis (NASH) in patients with obstructive sleep apnea. Accordingly, we hypothesized that recurrent and intermittent hypoxemia plays an important role in the pathogenesis of NASH. Our objective was construction of a practical and accurate experimental model to reproduce the key features of NASH in humans. Chemical hypoxemia through methemoglobinemia was induced by daily intraperitoneal injection of sodium nitrite (40 mg/kg) for 4 weeks in rats with fatty liver. The later was induced by 4-week feeding a choline-deficient high-fat diet (CDHF). Besides, the normal chow diets feeding groups were prepared with in the same manner except for CDHF feeding. The animal experiment was performed in four groups; Normal control, Hypoxemia, CDHF, and CDHF + hypoxemia. Nitrite was given for the later 4 weeks to each rat of Hypoxemia and CDHF + hypoxemia. CDHF + hypoxemia rats were confirmed to develop histological changes that resemble those of patients with NASH, together with biochemical liver dysfunction, while CDHF group was limited in mild steatosis, and Hypoxemia group liver was normal. Present study established a reproducible and useful NASH model resembling the main features of NASH in humans, and showed first that recurrent and intermittent hypoxemia aggravate fatty liver to steatohepatitis and liver fibrosis.

摘要

最近的报告描述了阻塞性睡眠呼吸暂停患者中非酒精性脂肪性肝炎(NASH)的高发率。因此,我们假设复发性和间歇性低氧血症在 NASH 的发病机制中起重要作用。我们的目的是构建一个实用且准确的实验模型,以重现人类 NASH 的关键特征。通过每天向脂肪肝大鼠腹腔内注射亚硝酸钠(40mg/kg),诱导化学性低氧血症通过高铁血红蛋白血症,持续 4 周。脂肪肝通过 4 周喂养胆碱缺乏高脂饮食(CDHF)诱导。此外,用相同的方法制备正常饲料喂养组,但不进行 CDHF 喂养。动物实验分为四组:正常对照组、低氧血症组、CDHF 组和 CDHF+低氧血症组。低氧血症和 CDHF+低氧血症组的每只大鼠在后期 4 周给予亚硝酸盐。CDHF+低氧血症组大鼠出现类似于人类 NASH 患者的组织学变化,同时伴有生化肝功能障碍,而 CDHF 组仅局限于轻度脂肪变性,低氧血症组肝脏正常。本研究建立了一个可重现的有用的 NASH 模型,类似于人类 NASH 的主要特征,并首次表明复发性和间歇性低氧血症可加重脂肪肝向脂肪性肝炎和肝纤维化的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/2771256/41cf6830cb69/jcbn09-29f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/2771256/11d358c32f2b/jcbn09-29f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/2771256/765c99ddf31b/jcbn09-29f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/2771256/b868d6c76da0/jcbn09-29f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/2771256/41cf6830cb69/jcbn09-29f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/2771256/11d358c32f2b/jcbn09-29f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/2771256/765c99ddf31b/jcbn09-29f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/2771256/b868d6c76da0/jcbn09-29f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a61/2771256/41cf6830cb69/jcbn09-29f04.jpg

相似文献

1
A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH.一种新型非酒精性脂肪性肝炎(NASH)动物模型:低氧血症增强 NASH 的发展。
J Clin Biochem Nutr. 2009 Nov;45(3):335-40. doi: 10.3164/jcbn.09-29. Epub 2009 Oct 28.
2
Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.支链氨基酸可减轻胆碱缺乏高脂饮食诱导的非酒精性脂肪性肝炎(NASH)小鼠的肝脂肪变性和肝损伤。
Metabolism. 2017 Apr;69:177-187. doi: 10.1016/j.metabol.2016.12.013. Epub 2017 Jan 4.
3
Utility of ultrasonography in a mouse model of non-alcoholic steatohepatitis induced by a choline-deficient, high-fat diet and dextran sulfate sodium.超声检查在胆碱缺乏、高脂饮食和葡聚糖硫酸钠诱导的非酒精性脂肪性肝炎小鼠模型中的应用
Biochem Biophys Rep. 2023 Nov 8;36:101575. doi: 10.1016/j.bbrep.2023.101575. eCollection 2023 Dec.
4
Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis.螺旋藻对非酒精性脂肪性肝炎大鼠模型的抗氧化和抗炎作用。
J Clin Biochem Nutr. 2012 Nov;51(3):227-34. doi: 10.3164/jcbn.12-18. Epub 2012 Oct 12.
5
Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.雷洛昔芬改善去卵巢小鼠胆碱缺乏高脂饮食诱导的非酒精性脂肪性肝炎肝纤维化
Dig Dis Sci. 2015 Sep;60(9):2730-9. doi: 10.1007/s10620-015-3660-6. Epub 2015 Apr 14.
6
Effects of docosahexaenoic acid in an experimental rat model of nonalcoholic steatohepatitis.二十二碳六烯酸在非酒精性脂肪性肝炎实验大鼠模型中的作用
J Oleo Sci. 2010;59(8):407-14. doi: 10.5650/jos.59.407.
7
Antifibrotic Effects of 1,25(OH)D on Nonalcoholic Steatohepatitis in Female Mice.1,25(OH)D 对雌性小鼠非酒精性脂肪性肝炎的抗纤维化作用。
Dig Dis Sci. 2019 Sep;64(9):2581-2590. doi: 10.1007/s10620-019-05560-3. Epub 2019 Mar 2.
8
Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet.虾青素通过下调去卵巢小鼠胆碱缺乏高脂饮食喂养下骨保护素的表达来减轻非酒精性脂肪性肝炎。
Dig Dis Sci. 2023 Jan;68(1):155-163. doi: 10.1007/s10620-022-07489-6. Epub 2022 Apr 10.
9
DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model.在胆碱缺乏的高脂饮食诱导的非酒精性脂肪性肝炎(NASH)小鼠模型中,葡聚糖硫酸钠(DSS)结肠炎促进肿瘤发生和纤维化。
Biochem Biophys Res Commun. 2016 Jan 29;470(1):15-21. doi: 10.1016/j.bbrc.2015.12.012. Epub 2015 Dec 10.
10
Utility of pemafibrate in nonalcoholic steatohepatitis model mice induced by a choline-deficient, high-fat diet and dextran sulfate sodium.佩马贝特在由胆碱缺乏、高脂饮食和葡聚糖硫酸钠诱导的非酒精性脂肪性肝炎模型小鼠中的效用。
Biochem Biophys Rep. 2024 May 3;38:101724. doi: 10.1016/j.bbrep.2024.101724. eCollection 2024 Jul.

引用本文的文献

1
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease.非酒精性脂肪性肝病与动脉粥样硬化性心血管疾病之间的相互作用。
Front Cardiovasc Med. 2023 May 2;10:1116861. doi: 10.3389/fcvm.2023.1116861. eCollection 2023.
2
Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies.不同动物模型和人类肝病病因中门静脉高压的不同结构和动力学成分。
Hepatology. 2022 Mar;75(3):610-622. doi: 10.1002/hep.32220. Epub 2021 Dec 20.
3
Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.

本文引用的文献

1
MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.蛋氨酸胆碱缺乏饮食诱导的脂肪性肝炎与肝脏脂联素抵抗及肝细胞脂肪生成转化有关。
J Hepatol. 2008 Sep;49(3):407-16. doi: 10.1016/j.jhep.2008.03.026. Epub 2008 Apr 30.
2
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis.肿瘤坏死因子基因多态性对日本非酒精性脂肪性肝炎和单纯性脂肪变性患者的影响。
J Hepatol. 2007 Jun;46(6):1104-10. doi: 10.1016/j.jhep.2007.01.028. Epub 2007 Feb 22.
3
The emerging biology of the nitrite anion.
缺氧诱导因子在非酒精性脂肪性肝病和非酒精性脂肪性肝炎发病机制中的关键作用
Front Med (Lausanne). 2021 Oct 6;8:753268. doi: 10.3389/fmed.2021.753268. eCollection 2021.
4
and its ingredient biopterin glucoside improved insulin sensitivity in non-alcoholic steatohepatitis model.其成分生物蝶呤葡糖苷在非酒精性脂肪性肝炎模型中改善了胰岛素敏感性。
J Clin Biochem Nutr. 2021 Sep;69(2):151-157. doi: 10.3164/jcbn.20-201. Epub 2021 Mar 25.
5
Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated Receptors.基于结构生物学的过氧化物酶体增殖物激活受体亚型选择性激动剂研究
Int J Mol Sci. 2021 Aug 26;22(17):9223. doi: 10.3390/ijms22179223.
6
Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea.持续气道正压通气治疗对阻塞性睡眠呼吸暂停患者非酒精性脂肪性肝病的影响。
World J Clin Cases. 2021 Jul 6;9(19):5112-5125. doi: 10.12998/wjcc.v9.i19.5112.
7
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model.非甾体类法尼醇X受体激动剂西洛菲克改善大鼠非酒精性脂肪性肝炎模型的门静脉高压并减轻肝纤维化
Biomedicines. 2021 Jan 9;9(1):60. doi: 10.3390/biomedicines9010060.
8
Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.持续气道正压通气治疗阻塞性睡眠呼吸暂停患者非酒精性脂肪性肝病。
J Clin Sleep Med. 2018 Aug 15;14(8):1315-1322. doi: 10.5664/jcsm.7262.
9
Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center.在一家三级医疗中心,阻塞性睡眠呼吸暂停是非酒精性脂肪性肝病患者肝纤维化的重要预测指标。
Hepatol Int. 2015 Apr;9(2):283-91. doi: 10.1007/s12072-015-9615-3. Epub 2015 Mar 12.
10
Reduction of oxidative stress attenuates lipoapoptosis exacerbated by hypoxia in human hepatocytes.氧化应激的降低可减轻人肝细胞中因缺氧而加剧的脂凋亡。
Int J Mol Sci. 2015 Feb 3;16(2):3323-34. doi: 10.3390/ijms16023323.
亚硝酸根阴离子的新兴生物学
Nat Chem Biol. 2005 Nov;1(6):308-14. doi: 10.1038/nchembio1105-308.
4
Chronic liver injury during obstructive sleep apnea.阻塞性睡眠呼吸暂停期间的慢性肝损伤。
Hepatology. 2005 Jun;41(6):1290-6. doi: 10.1002/hep.20725.
5
Model of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎模型
Am J Clin Nutr. 2004 Mar;79(3):502-9. doi: 10.1093/ajcn/79.3.502.
6
Sex differences in choline-deficient diet-induced steatohepatitis in mice.胆碱缺乏饮食诱导的小鼠脂肪性肝炎中的性别差异。
Exp Biol Med (Maywood). 2004 Feb;229(2):158-62. doi: 10.1177/153537020422900204.
7
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice.饮食相关的肝脂肪变性使小鼠对Fas介导的肝损伤敏感。
J Hepatol. 2003 Dec;39(6):978-83. doi: 10.1016/s0168-8278(03)00460-4.
8
Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies.非酒精性脂肪性肝炎的啮齿动物营养模型:物种、品系和性别差异研究
J Gastroenterol Hepatol. 2003 Nov;18(11):1272-82. doi: 10.1046/j.1440-1746.2003.03198.x.
9
Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎非糖尿病患者的肝细胞色素P450 2E1活性
Hepatology. 2003 Mar;37(3):544-50. doi: 10.1053/jhep.2003.50095.
10
Abnormal lipid peroxidation in patients with sleep apnoea.睡眠呼吸暂停患者脂质过氧化异常。
Eur Respir J. 2000 Oct;16(4):644-7. doi: 10.1034/j.1399-3003.2000.16d13.x.